A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 tria

J Sierra; J Szer; J Kassis; R Herrmann; M Lazzarino; X Thomas; SJ Noga; N Baker; R Dansey; A. Bosi

doi:https://doi.org/10.1186/1471-2407-8-195

A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 tria

J Sierra, J Szer, J Kassis, R Herrmann, M Lazzarino, X Thomas, SJ Noga, N Baker, R Dansey, A. Bosi

Department of Medicine

Research output: Contribution to journal › Article › Research

Original language	English
Pages (from-to)	195-195
Journal	BMC Cancer
Volume	10
Issue number	8
DOIs	https://doi.org/10.1186/1471-2407-8-195
Publication status	Published - 1 Jan 2008

Access to Document

https://doi.org/10.1186/1471-2407-8-195

https://ddd.uab.cat/record/112411

Cite this

Sierra, J., Szer, J., Kassis, J., Herrmann, R., Lazzarino, M., Thomas, X., Noga, SJ., Baker, N., Dansey, R., & Bosi, A. (2008). A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 tria. BMC Cancer, 10(8), 195-195. https://doi.org/10.1186/1471-2407-8-195

@article{871f0467fb4346068e08ae85ab26cde5,

title = "A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 tria",

author = "J Sierra and J Szer and J Kassis and R Herrmann and M Lazzarino and X Thomas and SJ Noga and N Baker and R Dansey and A. Bosi",

year = "2008",

month = jan,

day = "1",

doi = "https://doi.org/10.1186/1471-2407-8-195",

language = "English",

volume = "10",

pages = "195--195",

number = "8",

}

Sierra, J, Szer, J, Kassis, J, Herrmann, R, Lazzarino, M, Thomas, X, Noga, SJ, Baker, N, Dansey, R & Bosi, A 2008, 'A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 tria', BMC Cancer, vol. 10, no. 8, pp. 195-195. https://doi.org/10.1186/1471-2407-8-195

A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 tria. / Sierra, J; Szer, J; Kassis, J et al.

In: BMC Cancer, Vol. 10, No. 8, 01.01.2008, p. 195-195.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 tria

AU - Sierra, J

AU - Szer, J

AU - Kassis, J

AU - Herrmann, R

AU - Lazzarino, M

AU - Thomas, X

AU - Noga, SJ

AU - Baker, N

AU - Dansey, R

AU - Bosi, A.

PY - 2008/1/1

Y1 - 2008/1/1

U2 - https://doi.org/10.1186/1471-2407-8-195

DO - https://doi.org/10.1186/1471-2407-8-195

M3 - Article

VL - 10

SP - 195

EP - 195

IS - 8

ER -

Sierra J, Szer J, Kassis J, Herrmann R, Lazzarino M, Thomas X et al. A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 tria. BMC Cancer. 2008 Jan 1;10(8):195-195. doi: https://doi.org/10.1186/1471-2407-8-195